CiteAb and Antibody Validation - Andrew Chalmers
HTML-код
- Опубликовано: 16 сен 2024
- For more information about 1st International Antibody Validation Meeting 2014, please visit www.stjohnslab...
Antibody Validation Project (Free Trial Size Antibodies) www.stjohnslab...
Western Blotting (WB) - Video Protocol: • Western Blotting (WB) ...
ImmunoHistoChemistry (IHC) - Video Protocol: • ImmunoHistoChemistry (...
Immunocytochemistry (ICC) - Video Protocol: • Immunocytochemistry (I...
Dr Chalmers is a cell biologist based at the University of Bath, UK and he currently leads a team investigating the role of stem cell regulators in prostate cancer. In 2014 he was promoted to a Senior Lectureship. Dr Chalmers have published over 25 peer reviewed papers, been invited to national and international conferences and been awarded major research grants from research councils and charities. He is also the founder of CiteAb, a citation based antibody search engine. The idea of CiteAb was birthed through frustration with using failed commercial antibodies. CiteAb aims to provide a better way for researchers to find antibodies which are suitable for their experiments. CiteAb was spun out of the University of Bath in January 2014 and Dr Chalmers is the currently the Chief Scientific Officer.
Dr Chalmers is a cell biologist based at the University of Bath, UK and he currently leads a team investigating the role of stem cell regulators in prostate cancer. In 2014 he was promoted to a Senior Lectureship. Dr Chalmers have published over 25 peer reviewed papers, been invited to national and international conferences and been awarded major research grants from research councils and charities. He is also the founder of CiteAb, a citation based antibody search engine. The idea of CiteAb was birthed through frustration with using failed commercial antibodies. CiteAb aims to provide a better way for researchers to find antibodies which are suitable for their experiments. CiteAb was spun out of the University of Bath in January 2014 and Dr Chalmers is the currently the Chief Scientific Officer.